Cargando…
Targeting Caspase-3 as Dual Therapeutic Benefits by RNAi Facilitating Brain-Targeted Nanoparticles in a Rat Model of Parkinson’s Disease
The activation of caspase-3 is an important hallmark in Parkinson’s disease. It could induce neuron death by apoptosis and microglia activation by inflammation. As a result, inhibition the activation of caspase-3 would exert synergistic dual effect in brain in order to prevent the progress of Parkin...
Autores principales: | Liu, Yang, Guo, Yubo, An, Sai, Kuang, Yuyang, He, Xi, Ma, Haojun, Li, Jianfeng, Lv, Jing, Zhang, Ning, Jiang, Chen |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3652845/ https://www.ncbi.nlm.nih.gov/pubmed/23675438 http://dx.doi.org/10.1371/journal.pone.0062905 |
Ejemplares similares
-
Correction: Targeting Caspase-3 as Dual Therapeutic Benefits by RNAi Facilitating Brain-Targeted Nanoparticles in a Rat Model of Parkinson’s Disease
por: Liu, Yang, et al.
Publicado: (2013) -
A choline derivate-modified nanoprobe for glioma diagnosis using MRI
por: Li, Jianfeng, et al.
Publicado: (2013) -
Identification of Allele-Specific RNAi Effectors Targeting Genetic Forms of Parkinson's Disease
por: Sibley, Christopher R., et al.
Publicado: (2011) -
Lentiviral-mediated RNAi targeting caspase-3 inhibits
apoptosis induced by serum deprivation in rat endplate chondrocytes in
vitro
por: Ding, L., et al.
Publicado: (2014) -
Nanoparticle-Based RNAi Therapeutics Targeting Cancer Stem Cells: Update and Prospective
por: Tang, Yongquan, et al.
Publicado: (2021)